Education
About Us
Working with TipRanks
Follow Us
Clover Health Investments (CLOV)
NASDAQ:CLOV
CLOV Stock Chart & Stats
$1.89
-$0.09(-2.50%)
At close: 4:00 PM EST
$1.89
-$0.09(-2.50%)
Day’s Range― - ―
52-Week Range$1.85 - $3.92
Previous CloseN/A
Volume2.53M
Average Volume (3M)5.46M
Market Cap
$991.62M
Enterprise Value$889.34M
Total Cash (Recent Filing)$95.35M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.60
Next Earnings
May 12, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding428,951,420
10 Day Avg. Volume5,780,042
30 Day Avg. Volume5,455,864
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)3.94
Price to Sales (P/S)0.63
P/FCF Ratio-17.62
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue0.46
Enterprise Value/Gross Profit2.50
Enterprise Value/Ebitda-10.60
Forecast
1Y Price Target
$2.98Price Target Upside57.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.02
Revenue Forecast (FY)$2.87B
Bulls Say, Bears Say
Bulls Say
Clinical Technology Driving Cost ImprovementsWidespread adoption of the Clover Assistant by physicians is linked to lower medical cost ratios, improving unit economics for members who receive care from tool-using providers.
Member Retention And Market ConcentrationVery high member retention in markets with strong physician adoption of the clinical assistant helps new members generate better medical cost outcomes and supports sustainable unit economics.
Profitability Amid GrowthCompany achieved GAAP net income profitability while absorbing sizable membership growth, indicating ability to scale without sacrificing margins.
Bears Say
Guidance And Forecast UncertaintyAnalyst conservatism until the company issues formal guidance keeps earnings expectations uncertain and may weigh on investor confidence.
Medicare Advantage Rate UncertaintyMuted or disappointing Medicare Advantage rate updates create uncertainty about revenue per member and pose downside risk to margins.
Star Payment Level RiskPotential reversion to a lower star payment level could reduce plan payments and materially pressure future profitability.
Clover Health Investments News
CLOV FAQ
What was Clover Health Investments’s price range in the past 12 months?
Clover Health Investments lowest stock price was $1.85 and its highest was $3.92 in the past 12 months.
What is Clover Health Investments’s market cap?
Clover Health Investments’s market cap is $991.62M.
When is Clover Health Investments’s upcoming earnings report date?
Clover Health Investments’s upcoming earnings report date is May 12, 2026 which is in 51 days.
How were Clover Health Investments’s earnings last quarter?
Clover Health Investments released its earnings results on Feb 26, 2026. The company reported -$0.051 earnings per share for the quarter, beating the consensus estimate of -$0.102 by $0.051.
Is Clover Health Investments overvalued?
According to Wall Street analysts Clover Health Investments’s price is currently Undervalued.
Does Clover Health Investments pay dividends?
Clover Health Investments does not currently pay dividends.
What is Clover Health Investments’s EPS estimate?
Clover Health Investments’s EPS estimate is 0.07.
How many shares outstanding does Clover Health Investments have?
Clover Health Investments has 428,951,420 shares outstanding.
What happened to Clover Health Investments’s price movement after its last earnings report?
Clover Health Investments reported an EPS of -$0.051 in its last earnings report, beating expectations of -$0.102. Following the earnings report the stock price went down -2.791%.
Which hedge fund is a major shareholder of Clover Health Investments?
Currently, no hedge funds are holding shares in CLOV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clover Health Investments Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.98 (57.67% Upside)
$2.98 (57.67% Upside)
Blogger Sentiment
Bullish
CLOV Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $379.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days <0.1%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.36%
12-Months-Change
Fundamentals
Return on Equity
-25.73%
Trailing 12-Months
Asset Growth
-6.84%
Trailing 12-Months
Company Description
Clover Health Investments
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
CLOV Company Deck
CLOV Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
While Clover Health reported significant membership and revenue growth, positive EBITDA, and strong retention rates, the call highlighted challenges with new member profitability, lowered financial guidance, and increased medical costs, leading to a balanced outlook.View all CLOV earnings summariesCLOV Stock 12 Month Forecast
Average Price Target
$2.98
▲(57.67% Upside)
Technical Analysis
Ownership Overview
6.51% Insiders
7.73% Mutual Funds
0.68% Other Institutional Investors
75.05% Public Companies and
Individual Investors